Skip to main content
. 2016 Dec 23;8(4):6446–6460. doi: 10.18632/oncotarget.14119

Figure 1. Overexpression of β-ARs in breast cancer.

Figure 1

(A) Representative images of IHC for the β-AR receptors in normal (N = 5) and malignant breast tissue (N = 20). (B) Box and whiskers plot illustrating the expression of β-ARs in the panel of normal and malignant breast tissue.